Sponsored by the North American Center for Continuing Medical Education (NACCME)
Target Audience
This activity is intended for physicians, nurses, and technologists
Topics
Module # 1 Volume Echocardiography and Knowledge Based Workflow
Module # 2 Calcium Scoring and Cardiac Perfusion
Module # 3 Innovated Imaging and Archiving Solutions in the Pediatric Cath Lab
Module # 4 Cardiovascular Magnetic Resonance in CAD
Module # 5 Nuclear Cardiology in Diagnosing Coronary Artery Disease
Module # 6 3D Echocardiography of the Mitral Valve
Learning Objectives
Module # 1 Learning Objectives:
Upon completion of this educational activity, participants should be able to:
- describe the principles of real-time volume imaging
- discuss the clinical applications of real-time volume imaging
- apply real-time volume imaging to improve workflow in the echo lab
Module # 2 Learning Objectives:
Upon completion of this educational activity, participants should be able to:
- identify the role of coronary calcium scoring as a marker of cardiovascular risk
- discuss the clinical value of myocardial perfusion imaging for ischemia testing in the workup of coronary artery disease
- identify clinical scenarios in which a stepwise or combined usage of both, calcium scoring, as well as perfusion imaging, may be beneficial
Module # 3 Learning Objectives:
Upon completion of this educational activity, participants should be able to:
- describe the basic elements of setting up a new cath lab
- discuss how picture archiving and communication systems will be helpful
- make informed decisions based on the learner’s needs
Module # 4 Learning Objectives:
Upon completion of this educational activity, participants should be able to:
- Recognize the role of cardiovascular MRI in the diagnosis of coronary artery disease
- Explain the basic techniques used for MRI of the cardiovascular system
- Identify the pitfalls and challenges of cardiovascular MRI
Module # 5 Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Describe the strengths and weaknesses of nuclear cardiology for diagnosing coronary artery disease and assessing its extent and severity
- Discuss new nuclear approaches and consider how they may impact the ability of nuclear cardiology to diagnose coronary artery disease
Module # 6 Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Understand the advantages of 3-D echo in the diagnosis of valvular heart disease
- Apply 3-D Echo in the diagnosis and management of valvular heart disease
- Understand the potential for real-time quantification of valve flow using real-time volume imaging
Medium Used & Method of Participation
Watch the webcast, participate in the post-test/evaluation and get your documentation of credit immediately.
Successful Completion
To be eligible for documentation of credit, participants must watch the webcast, log on to www.naccme.com and complete the post-test with a score of 70% or better, and complete the online evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit. Please e-mail info@naccme.com or call 609-371-1137 if you have questions or need additional information.
Module # 1
Release Date: 11/03/08 Expiration Date: 11/03/09
Module # 2
Release Date: 11/03/08 Expiration Date: 11/03/09
Module # 3
Release Date: 11/03/08 Expiration Date: 11/03/09
Module # 4
Release Date: 12/22/08 Expiration Date: 12/22/09
Module # 5
Release Date: 03/30/09 Expiration Date: 03/30/10
Module # 6
Release Date: 04/09/09 Expiration Date: 04/09/10
Estimated time to complete activity: 1 hour each module
There is no fee for participation in this activity.
Media or combination of media used: The activity content, post-test, and evaluation form are available as a click-through via the menu at the top of this page.
Accreditation statements:
CME Accreditation:
This activity is sponsored by North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE Accreditation
ANCC: NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour. Provider #: 110-3-E-06. Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1 contact hour.
ARRT Accreditation
Module #1
AHRA-Approved for 1 Category A, ARRT continuing education credit
Module #2
AHRA-Approved for 1 Category A, ARRT continuing education credit
Module #3
AHRA-Approved for 1 Category A, ARRT continuing education credit
Module #4
AHRA-Approved for 1 Category A, ARRT continuing education credit
Module #5
AHRA-Approved for 1 Category A, ARRT continuing education credit
Module #6
AHRA-Approved for 1 Category A, ARRT continuing education credit
Grievance Policy
Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by Princeton CME may contact John Savage, Director, Medical Education, North American Center for Continuing Medical Education (NACCME), in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535; e-mail: jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME-Princeton CME, may be made for a second level of review.
Grant Support
Supported by an educational grant from: Siemens
Presenters/Faculty
Module # 1:
Mani A. Vannan, MBBS, FACC
Professor of Clinical Medicine
Division of Cardiovascular Medicine
Director of Cardiovascular Imaging
Ohio State University
Columbus, OH
Module # 2
Frank M. Bengel, M.D.
Associate Professor of Radiology and Medicine
Johns Hopkins University
Division of Nuclear Medicine
Baltimore, MD
Module # 3
Thomas Forbes, M.D.
Associate Professor (Clinical-Educator)
Division of Pediatric Cardiology
Children’s Hospital of Michigan
Wayne State University
Detroit, MI 48201
Module # 4
Orlando "Lon" Simonetti, PhD
Associate Professor of Internal Medicine and Radiology
The Ohio State University
Columbus, Ohio
Module # 5
Timothy Bateman, MD
Co-Director, Cardiovascular Radiologic Imaging
Cardiovascular Consultants PA
Kansas City, Missouri
Module # 6
Mani A. Vannan, MBBS, FACC
Professor of Clinical Medicine
Division of Cardiovascular Medicine
Director of Cardiovascular Imaging
Ohio State University
Columbus, Ohio
Independent Clinical Reviewer
Robert Dieter, M.D.
Vascular and Endovascular Medicine
Interventional Cardiology
Assistant Professor of Medicine
Section of Cardiovascular Medicine
Loyola University Medical Center
Maywood, IL
Disclosure and Conflict of Interest Policy
All faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME, LLC to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
Faculty Disclosures
Module # 1
Dr. Vannan has disclosed that he has received grant/research support and is a scientific advisor for Siemens.
Clinical Reviewer: Dr. Dieter has disclosed that he has no relevant financial relationship with any commercial interest.
Planning Committee: T. Levy, NACCME and N. Otranto and L. Mazzagatti, HMP Communications have disclosed that they have no relevant financial relationship with any commercial interest.
Module # 2
Dr. Bengel has disclosed that he has received grant/research support from Lantheus Medical imaging and GE Medical Systems. He is a scientific advisor to GE Healthcare and has received speaker support from GE Healthcare, Siemens Medical Systems, and BayerSchering Pharma.
Clinical Reviewer: Dr. Dieter has disclosed that he has no relevant financial relationship with any commercial interest.
Planning Committee: T. Levy, NACCME and N. Otranto and L. Mazzagatti, HMP Communications have disclosed that they have no relevant financial relationship with any commercial interest.
Module # 3
Dr. Forbes has disclosed that he has no relevant financial relationship with any commercial interest.
Clinical Reviewer: Dr. Dieter has disclosed that he has no relevant financial relationship with any commercial interest.
Planning Committee: T. Levy, NACCME and N. Otranto and L. Mazzagatti, HMP Communications have disclosed that they have no relevant financial relationship with any commercial interest.
Module # 4
Dr. Simonetti has disclosed that he has received grant/research support from Siemens Healthcare and he is an employee/officer or Board member for ECMR, Ltd.
Clinical Reviewer: Dr. Dieter has disclosed that he has no relevant financial relationships with any commercial interest
Planning Committee: T. Levy, NACCME and N. Otranto and L. Mazzagatti, HMP Communications have disclosed that they have no relevant financial relationship with any commercial interest.
Module # 5
Dr. Bateman has disclosed that he has received grant/research support from Bracco, Philips and Astellas. He is a consultant to Covidien. He is a member of the speakers bureau for Bracco and Astellas and is a stock shareholder in Cardiovascular Imaging Technologies, Inc.
Clinical Reviewer: Dr. Dieter has disclosed that he has no relevant financial relationship with any commercial interest.
Planning Committee: T. Levy and L. Mazzagatti, NACCME, and N. Otranto HMP Communications have disclosed that they have no relevant financial relationship with any commercial interest.
Module # 6
Dr. Vannan has disclosed that he has received grant/research support and is a scientific advisor for Siemens.
Clinical Reviewer: Dr. Dieter has disclosed that he has no relevant financial relationship with any commercial interest.
Planning Committee: T. Levy and L. Mazzagatti, NACCME, and N. Otranto HMP Communications have disclosed that they have no relevant financial relationship with any commercial interest.
Off label/unapproved use statement and disclosure
NACCME, LLC requires faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentations.
Privacy Policy
NACCME, LLC protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME-Princeton CME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME, LLC maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2008 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the North American Center for Continuing Medical Education.
